Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer.

Powell Gray B, Kelly L, Ahrens DP, Barry AP, Kratschmer C, Levy M, Sullenger BA.

Proc Natl Acad Sci U S A. 2018 May 1;115(18):4761-4766. doi: 10.1073/pnas.1717705115. Epub 2018 Apr 16.

2.

Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers.

Kratschmer C, Levy M.

Mol Ther Nucleic Acids. 2018 Mar 2;10:227-236. doi: 10.1016/j.omtn.2017.11.013. Epub 2017 Dec 1.

3.

Effect of Chemical Modifications on Aptamer Stability in Serum.

Kratschmer C, Levy M.

Nucleic Acid Ther. 2017 Dec;27(6):335-344. doi: 10.1089/nat.2017.0680. Epub 2017 Sep 25.

4.

Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate.

Kelly L, Kratschmer C, Maier KE, Yan AC, Levy M.

Nucleic Acid Ther. 2016 Jun;26(3):156-65. doi: 10.1089/nat.2015.0599. Epub 2016 May 26.

Supplemental Content

Loading ...
Support Center